Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Reports from Bristol-Myers Squibb Company advance knowledge in type 2 diabetes
2009 JUN 29 -- According to a study from the United States, "The study aim was to evaluate the efficacy and safety of initial combination therapy with saxagliptin + metformin vs. saxagliptin or metformin monotherapy in treatment-naive patients with type 2 diabetes (T2D) and inadequate glycaemic control. In this multicentre, randomized, double-blind, active-controlled phase 3 trial, 1306 treatment-naive patients with T2D >= 18 to <= 77 years, glycosylated haemoglobin (HbA1c ) >= 8 to <= 12%, fasting C-peptide concentration >= 1.0 ng/ml, body mass index <= 40 kg/m(2) were randomized to receive saxagliptin 5 mg + metformin 500 mg, saxagliptin 10 mg +...
In order to view the entire article, please read your options to the right
